| Autor: |
Stan, Mihai-Cosmin, Mireștean, Ciprian-Camil, Stoica, Daniel, Popescu, Carmen-Florina, Bădulescu, Florinel |
| Předmět: |
|
| Zdroj: |
Oncolog-Hematolog; 2023, Issue 64, p46-46, 2/3p |
| Abstrakt: |
Introduction. Type 2 diabetes and cancer are the most important public health problems nowadays, and the mechanisms between the presence of diabetes and the development of malignancies remain unclear. The leading cause of cancer death in 2020 is attributed to lung cancer. This study aimed to highlight the impact of the association of these two diseases and the predominant histopathological type of lung cancer in the selected group, the glycemic imbalance, and information about the course and outlook for these patients. Materials and method. The authors proposed a case-control 10-year period study, between 2007 and 2017, of two groups of patients diagnosed with type 2 diabetes and lung cancer who underwent hospitalization in the Medical Clinic of Oncology of the Craiova Clinical District Hospital (ECCHC). Results. Our study showed a higher incidence of lung adenocarcinoma in patients diagnosed with type 2 diabetes. The inflammatory syndrome is more pronounced in the diabetic group, which is supported by correlations between lactate dehydrogenase (LDH), albumin and hemoglobin levels. The duration of cancer treatment in lung cancer and the survival rate are strongly influenced by the presence of diabetes as a concomitant disease. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
